The Seattle Hub for Synthetic Biology is receiving a $10 million grant to support the training of new scientists and the ...

An experimental stem cell therapy reversed corneal damage in half of the participants from a recent clinical trial.

A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem ...

Garuda Therapeutics (Garuda), a biotechnology company creating off-the-shelf, HSC therapies for a multitude of blood ...

A new, alternative treatment for those patients may be surgical removal of the abnormal blood vessels followed by the transplantation of stem cell-derived retinal cells, according to a recent study ...